October's round-up of some of the latest research and education stories from the University.
Improving cancer treatments and patient care through collaboration
Researchers in Yorkshire are collaborating on a new national data hub that aims to transform how cancer data from across the UK can be used to improve patient care.
Collaborators from Yorkshire and Humber include the University of Leeds, Leeds Teaching Hospitals NHS Trust, University of Sheffield, Sheffield Teaching Hospitals, Sheffield Childrens Hospitals, Yorkshire and Humber Local Health Care Record, and Yorkshire & Humber Academic Health Science Network.
The work has been awarded £4.5 million to deliver DATA-CAN, the Health Data Research Hub for Cancer.
Another exciting Light Night in Leeds
Art and biology met on campus for another year of Light Night.
Light Night is the UKs largest annual arts and light festival. It will see the transformation of some of Leeds' most recognisable indoor and outdoor spaces during two special nights.
Visitors were invited to step inside The Nectary - a series of huge, glowing flower heads, carefully crafted from recycled plastic and hung from trees in University Square - amongst other amazing cultural attractions on campus.
Watch the Research Spotlight
Leeds scientists reveal gender gaps in heart attack care
In partnership with the British Heart Foundation, Leeds researchers have helped to highlight the inequalities in awareness, diagnosis, treatment and care for women suffering a heart attack.
Professor Chris Gale's research looked at the disparity in care for men and women after experiencing a heart attack. The new report was covered widely, including extensively on the BBC.
Scientists have uncovered a novel approach to prevent and treating a widespread superbug
Working with researchers across the UK and in Germany, Leeds scientists have developed an approach to tackling a widespread superbug using natural ingredients.
The bug, Helicobacter pylori (H. pylori), is a bacterial pathogen carried by 4.4 billion people worldwide, with the highest prevalence in Africa, Latin America and the Caribbean.
Although the majority of infections show no symptoms, if left untreated the pathogen can cause chronic inflammation of the stomach lining, ulcers and is associated with an increased risk of gastric cancer.
Current treatments involve multi-target therapy with a combination of antibiotics, but this has promoted the emergence of resistant strains.
Scientists have now uncovered a novel antibiotic-free approach using only food- and pharmaceutical-grade ingredients.